Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

John Reneau

Clinical trials sponsored by John Reneau, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Off-the-Shelf immune cells take on Hard-to-Treat lymphomas Results expected Oct 2026 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Completed 1
Sort by
  • Can a drug duo outsmart resistant T-Cell lymphoma?

    Disease control Completed

    This phase II trial is testing whether combining brentuximab vedotin, a targeted antibody-drug conjugate, with lenalidomide, a chemotherapy drug, can shrink tumors in people with T-cell lymphoma that has relapsed or not responded to earlier treatment. The study enrolls adults wit…

    Phase 2 • Sponsor: John Reneau • Aim: Disease control

    Last updated Aug 15, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space